Clinical Trials Browser

Phase 1 × Advanced Malignancy × tremelimumab × Clear all

NCT02978482 2021-08-18

A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies

Phase 1 Completed

Advanced Malignancy